Marina Pulido
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older - final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE study.
Journal: Breast (Edinburgh, Scotland)
Published: November 27, 2025
Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.
Journal: ESMO open
Published: November 11, 2025
Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 15, 2024
Health literacy and the use of digital tools in older patients with cancer and their younger counterparts: A multicenter, nationwide study.
Journal: Patient education and counseling
Published: March 14, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Journal: Molecular cancer
Published: December 05, 2023
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
Journal: Journal of hematology & oncology
Published: August 31, 2022
BIOPSAR study: ultrasound-guided pre-operative biopsy to assess histology of sarcoma-suspicious uterine tumors: a new study protocol.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 17, 2021
Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 20, 2021
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy.
Journal: Diagnostic and interventional imaging
Published: February 02, 2021
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2019
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Journal: British journal of cancer
Published: March 25, 2019
Last Updated: 09/26/2026